Mira Health Products Biogenix USA Prematif Male capsules Recall

Why it was recalled

The dietary supplements have the potential to be contaminated with undeclared steroids, pharmaceutical ingredients and/or chemical additives due to lack of GMPs.

Product description

Biogenix USA Prematif Male capsules, packaged as a bulk product in clear plastic bags.

Lot numbers, UPCs & expiration codes

All lots within expiry and distributed prior to August 2013

Where it was sold

GA, FL, NC, possibly NJ and New Zealand

What to do if you have this product

Compare the brand, size, and lot/UPC codes on your package with the codes above.
If it matches, don't eat it. Return it to the store for a refund or throw it away.
Wash surfaces and containers that touched the product.
If you feel sick after eating it, contact your doctor. In an emergency call 911.

Recall details

Recall number: F-1328-2014
Classification: Class II
Status: Terminated
Recall initiated: Sep 4, 2013
FDA report date: Jan 8, 2014
Quantity: unknown
Recall type: Voluntary: Firm initiated
Recalling firm: Mira Health Products Ltd.

Original FDA data

Every field from FDA enforcement report F-1328-2014, exactly as published.

Show all FDA fields

City: Farmingdale
State: NY
Status: Terminated
Country: United States
Event ID: 65916
Address: 65 E Carmans Rd
Code information: All lots within expiry and distributed prior to August 2013
Postal code: 11735-3834
Report date: Jan 8, 2014
Product type: Food
Recall number: F-1328-2014
Classification: Class II
Recalling firm: Mira Health Products Ltd.
Product quantity: unknown
Termination date: Nov 26, 2014
Reason for recall: The dietary supplements have the potential to be contaminated with undeclared steroids, pharmaceutical ingredients and/or chemical additives due to lack of GMPs.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Biogenix USA Prematif Male capsules, packaged as a bulk product in clear plastic bags.
Distribution pattern: GA, FL, NC, possibly NJ and New Zealand
Recall initiation date: Sep 4, 2013
Initial firm notification: Letter
Center classification date: Dec 27, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report F-1328-2014, published Jan 8, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions.